NGL FINECHEM
|
The Current P/S Ratio of NGL FINECHEM is 1.76.
Share Price | ₹1,058.4 | Apr 11,2025 |
Market Cap | ₹656.2 Cr | |
Sales-TTM | ₹373.1 Cr | TTM-Consolidated Results |
Price/Sales | 1.76x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of NGL FINECHEM
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹656.2 Cr] as on Apr 11,2025
(/) Sales [ ₹373.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.76x ]
Thus, for NGL FINECHEM , the investors are currently willing to pay '1.76 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NGL FINECHEM !
The chart below summarizes the trend in P/S Ratio of NGL FINECHEM over the last five years.
Historical PS (Price/Sales) ratio chart of NGL FINECHEM
PS Ratio Performance Analysis for NGL FINECHEM
- NGL FINECHEM 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.00x.
- NGL FINECHEM 's operated at median p/e ratio of 3.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/e ratio peaked in Mar2024 at 3.81x.
- NGL FINECHEM 's p/e ratio hit its five-year low in Mar2020 of 1.03x.
How does NGL FINECHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
NGL FINECHEM | 373.1 | 1.76 | 656.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.85 | 404,900.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.36 | 148,474.0 |
CIPLA LTD | 26,981.2 | 4.38 | 118,166.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.37 | 105,849.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 2.96 | 92,553.6 |
MANKIND PHARMA LTD | 11,641.0 | 8.33 | 97,009.6 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 3.93 | 87,366.3 |
LUPIN LTD | 22,001.6 | 4.09 | 89,899.9 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.03 | 62,874.7 |
ABBOTT INDIA LTD | 6,243.2 | 10.07 | 62,852.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NGL FINECHEM 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.76x |
Max industry PS | 16.36x |
Median industry PS | 4.38x |
Average industry PS | 6.47x |
You may also like the below Video Courses